Amgen, Inc.

( )
AMGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -2.43%67.830.0%$2120.05m
NVAXNovavax, Inc. 7.12%133.2896.5%$1132.56m
SRNESorrento Therapeutics, Inc. 4.84%13.011.5%$802.96m
GILDGilead Sciences, Inc. -0.96%68.181.0%$567.95m
AMGNAmgen, Inc. -0.52%240.461.3%$471.70m
REGNRegeneron Pharmaceuticals, Inc. -0.24%610.892.7%$384.77m
VRTXVertex Pharmaceuticals, Inc. -1.37%267.151.9%$353.16m
BNTXBioNTech SE 2.74%71.000.0%$353.03m
ILMNIllumina, Inc. 2.73%353.533.5%$351.76m
BIIBBiogen, Inc. -1.60%288.541.6%$350.10m
ATNMActinium Pharmaceuticals, Inc. 3.77%9.9113.3%$236.61m
VXRTVaxart, Inc. -1.20%9.090.0%$212.23m
EBSEmergent BioSolutions, Inc. 4.17%134.976.4%$199.46m
MCRBSeres Therapeutics, Inc. 21.31%28.583.6%$186.90m
ALXNAlexion Pharmaceuticals, Inc. -0.87%101.892.0%$163.07m

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.